SPRY
ARS Pharmaceuticals Inc
$4.50
-5.46% ($0.26)
Volume
2.17M
52W High
$13.15
52W Low
$4.46
Market Cap
$599.79M
Next Earnings Report
Last Reported
Aug 13, 2026 Beat
Actual: -$0.46
vs. Consensus: -$0.55
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q2 2026
Aug 13, 2026
1-Day:
-7.38%
5-Day:
+3.28%
Q2 2026
Aug 12, 2026
1-Day:
+0.83%
5-Day:
+3.14%
Q1 2026
May 19, 2026
1-Day:
+8.79%
Q1 2026
May 15, 2026
5-Day:
+5.05%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'25 | $32.5M | +1,471.6% | 74.8% | -163.7% | -$51.2M |
| Q2'25 | $15.7M | +3,043.4% | 68.3% | -303.0% | -$44.9M |
| Q1'25 | $8.0M | +10,000.0% | 49.3% | -466.3% | -$33.9M |
| Q4'24 | $86.6M | +10,000.0% | 95.5% | 54.5% | $49.9M |
| Q3'24 | $2.1M | +994.2% | 94.6% | -1,051.6% | -$19.1M |
| Q2'24 | $500,000 | +7.8% | 100.0% | -3,068.0% | -$12.5M |
| Q2'23 | $10,000 | -98.5% | -10,000.0% | -10,000.0% | -$17.4M |
| Q1'23 | $20,000 | -97.4% | -10,000.0% | -10,000.0% | -$15.0M |
Company Information
Symbol
SPRY
Company
ARS Pharmaceuticals Inc
Market Cap
$599.79M